Creative Medical Technology Holdings, Inc.

NasdaqCM:CELZ Stock Report

Market Cap: US$4.5m

Creative Medical Technology Holdings Future Growth

Future criteria checks 3/6

Creative Medical Technology Holdings is forecast to grow earnings and revenue by 72.7% and 86.8% per annum respectively while EPS is expected to grow by 63.3% per annum.

Key information

72.7%

Earnings growth rate

63.3%

EPS growth rate

Biotechs earnings growth28.4%
Revenue growth rate86.8%
Future return on equityn/a
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

NasdaqCM:CELZ - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-6N/AN/A1
12/31/2025N/A-4N/AN/A1
12/31/2024N/A-5N/AN/A1
9/30/20240-5-5-5N/A
6/30/20240-6-6-6N/A
3/31/20240-5-5-5N/A
12/31/20230-5-8-8N/A
9/30/20230-10-10-10N/A
6/30/20230-9-9-9N/A
3/31/20230-10-10-10N/A
12/31/20220-10-8-8N/A
9/30/20220-8-5-5N/A
6/30/20220-9-5-5N/A
3/31/20220-10-3-3N/A
12/31/2021019-2-2N/A
9/30/20210-16-1-1N/A
6/30/20210-13-1-1N/A
3/31/20210-12-1-1N/A
12/31/20200-36-10N/A
9/30/20200-3-1-1N/A
6/30/20200-6-1-1N/A
3/31/20200-4-1-1N/A
12/31/20190-8-1-1N/A
9/30/20190-1-1-1N/A
6/30/20190-1-1-1N/A
3/31/20190-7-1-1N/A
12/31/20180-14-1-1N/A
9/30/20180-17-1-1N/A
6/30/20180-16N/A-1N/A
3/31/20180-10N/A-1N/A
12/31/20170-3N/A-1N/A
9/30/2017N/A-1N/A-1N/A
6/30/2017N/A-2N/A-1N/A
3/31/2017N/A-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CELZ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: CELZ is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CELZ is expected to become profitable in the next 3 years.

Revenue vs Market: CELZ is forecast to have no revenue next year.

High Growth Revenue: CELZ is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CELZ's Return on Equity is forecast to be high in 3 years time


Discover growth companies